IBRN Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
October 8 at 9:45 AM ET (Korea 10/8 22:45)
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.47% | Return% 1Y | 15.84% | Total Holdings | 81 | Perf Week | -4.48% | Volume | 321 |
| Asset Type | Equities (Stocks) | AUM | $6M | Return% 3Y | 16.09% | NAV | $31.87 | Perf Month | -17.38% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | $0.32 (1.02%) | Return% 5Y | - | 52W High | -27.01% | Perf Quarter | -19.61% | Rel Volume | 0.11 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 14.56% | Perf Half Y | -7.93% | Prev Close | $31.86 |
| IPO | 2022/8/26 | Flows% 1M | 0% | Return% SI | 6.89% | RSI (14) | 18.12 | Perf YTD | -2.87% | Price | $31.39 |
| Beta | 0.66 | Flows% 3M | 42.58% | Flows% YTD | 42.58% | Flows% 1Y | 42.58% | Perf Year | 12.02% | Volatility(W/M) | 1.03% 1% |
| SMA20 | -8.17% | SMA50 | -15.27% | SMA200 | -9.93% | ATR | 0.56 | ||||
iShares Neuroscience and Healthcare ETFIBRN | NYSE | Healthcare sector iShares Neuroscience and Healthcare ETF seeks to track the NYSE FactSet Global Neuro Biopharma and MedTech Index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience. The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
The top 10 make up 56% of the fund
DNTH Dianthus Therapeutics Inc 5.34% 3 
XENE Xenon Pharmaceuticals Inc 4.87% 4 
PRAX Praxis Precision Medicines Inc 4.87% 5 
ACAD ACADIA PHARMACEUTICALS INC. 4.69% 6 
ARWR ARROWHEAD PHARMACEUTICALS, INC. 4.65% 7 
ALKS ALKERMES PUBLIC LIMITED COMPANY 4.60% 8 
SRRK Scholar Rock Holding Corp 4.29% 9 
BIIB BIOGEN INC. 4.18% 10 
NBIX NEUROCRINE BIOSCIENCES, INC. 4.09% Largest sectors first.
Over the past 1 year, roughly in the middle
27% below its 1-year high.
Traded less than usual That is 11% of its average volume.
Long-term returns are roughly flat
Bought 3 years ago, your return today would be +48.4%.
Tap to view numbers
The price swings a lot
At its worst (November 2024) it fell 35% and took 191 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 1.02% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 42.6% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 162M 
RXL ProShares Ultra Health Care 2X Shares 94M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 28M 
RXD-1× ProShares UltraShort Health Care -2x Shares 4M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
BBH VanEck Biotech ETF 0.35% 
IDNA iShares Genomics Immunology and Healthcare ETF 0.47% 
MEDI Harbor Health Care ETF 0.8% 
GDOC Goldman Sachs Future Health Care Equity ETF 0.75% 
MEDX Horizon Kinetics Medical ETF 0.85% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does IBRN have?
IBRN holds a total of 81 securities, with an AUM of approximately $6M.
Does IBRN pay dividends (distributions)?
IBRN's distribution yield is approximately 1.02%.
What is the 52-week high and low for IBRN?
IBRN has recorded a 52-week high of $43.01 and a low of $27.40.
